Solvay files for pancrelipase approval in Japan
This article was originally published in Scrip
Executive Summary
Solvay has filed for the approval of the pancreatic enzyme replacement therapy pancrelipase (SA-001) in Japan. The product was co-developed for this market with Eisai, which will distribute it should it be approved.